Puma Biotechnology, Inc. SEC filings PBYI

Puma Biotechnology, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Oct 25, 2012. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Puma Biotechnology, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 6, 2026 —
4 Insider transaction Sep 16, 2026 Sep 14, 2026
4 Insider transaction Sep 16, 2026 Sep 14, 2026
144 Notice of proposed sale Sep 14, 2026 —
144 Notice of proposed sale Sep 14, 2026 —
4 Insider transaction Jul 8, 2026 Jul 6, 2026
4 Insider transaction Jul 8, 2026 Jul 6, 2026
4 Insider transaction Jul 8, 2026 Jul 6, 2026
144 Notice of proposed sale Jul 6, 2026 —
144 Notice of proposed sale Jul 6, 2026 —
144 Notice of proposed sale Jul 6, 2026 —
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
144 Notice of proposed sale Jun 12, 2026 —
144 Notice of proposed sale Jun 12, 2026 —
144 Notice of proposed sale Jun 12, 2026 —
144 Notice of proposed sale Jun 12, 2026 —
144 Notice of proposed sale Jun 12, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
4 Insider transaction Nov 13, 2025 Nov 11, 2025
144 Notice of proposed sale Nov 12, 2025 —
4 Insider transaction Jul 22, 2025 Jul 18, 2025
144 Notice of proposed sale Jul 18, 2025 —
4 Insider transaction Jul 10, 2025 Jul 8, 2025
4 Insider transaction Jul 10, 2025 Jul 8, 2025
4 Insider transaction Jul 10, 2025 Jul 8, 2025
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 8, 2025 —
144 Notice of proposed sale Jul 8, 2025 —
144 Notice of proposed sale Jul 8, 2025 —
4 Insider transaction Jun 17, 2025 Jun 13, 2025
4 Insider transaction Jun 17, 2025 Jun 13, 2025
4 Insider transaction Jun 17, 2025 Jun 13, 2025
4 Insider transaction Jun 17, 2025 Jun 13, 2025
4 Insider transaction Jun 17, 2025 Jun 13, 2025
4 Insider transaction Jun 17, 2025 Jun 13, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
144 Notice of proposed sale Jun 13, 2025 —
144 Notice of proposed sale Jun 13, 2025 —
144 Notice of proposed sale Jun 13, 2025 —
144 Notice of proposed sale Jun 13, 2025 —
144 Notice of proposed sale Jun 13, 2025 —
144 Notice of proposed sale Jun 13, 2025 —
144 Notice of proposed sale May 21, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 17, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Feb 11, 2025 Feb 7, 2025
4 Insider transaction Feb 11, 2025 Feb 7, 2025
4 Insider transaction Feb 11, 2025 Feb 7, 2025
4 Insider transaction Feb 11, 2025 Feb 7, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 3, 2025 —
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 8, 2024 —
SC 13G Ownership over 5% (passive) Oct 22, 2024 —
4 Insider transaction Aug 13, 2024 Aug 12, 2024
144 Notice of proposed sale Aug 12, 2024 —
4 Insider transaction Jul 18, 2024 Jul 17, 2024
4 Insider transaction Jul 18, 2024 Jul 17, 2024
4 Insider transaction Jul 18, 2024 Jul 17, 2024
4 Insider transaction Jul 18, 2024 Jul 17, 2024
144 Notice of proposed sale Jul 17, 2024 —
144 Notice of proposed sale Jul 17, 2024 —
144 Notice of proposed sale Jul 17, 2024 —
144 Notice of proposed sale Jul 17, 2024 —
4 Insider transaction Jul 2, 2024 Jul 2, 2024
4 Insider transaction Jul 2, 2024 Jul 2, 2024
4 Insider transaction Jul 2, 2024 Jul 2, 2024
4 Insider transaction Jul 2, 2024 Jul 2, 2024
144 Notice of proposed sale Jul 2, 2024 —
144 Notice of proposed sale Jul 2, 2024 —
144 Notice of proposed sale Jul 2, 2024 —
144 Notice of proposed sale Jul 2, 2024 —
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
144 Notice of proposed sale Jun 13, 2024 —
144 Notice of proposed sale Jun 13, 2024 —
144 Notice of proposed sale Jun 13, 2024 —
144 Notice of proposed sale Jun 13, 2024 —
144 Notice of proposed sale Jun 13, 2024 —
SC 13G Ownership over 5% (passive) Mar 29, 2024 —
4 Insider transaction Mar 19, 2024 Mar 15, 2024
4 Insider transaction Feb 14, 2024 Feb 12, 2024
4 Insider transaction Feb 14, 2024 Feb 12, 2024
4 Insider transaction Feb 14, 2024 Feb 12, 2024
4 Insider transaction Feb 14, 2024 Feb 12, 2024
4 Insider transaction Feb 14, 2024 Feb 12, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 6, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 30, 2024 —
4 Insider transaction Jan 10, 2024 Dec 4, 2023
144/A Filing Jan 10, 2024 —
4 Insider transaction Jan 5, 2024 Jan 3, 2024
4 Insider transaction Jan 5, 2024 Jan 3, 2024
4 Insider transaction Jan 5, 2024 Jan 3, 2024
4 Insider transaction Jan 5, 2024 Jan 3, 2024
4 Insider transaction Jan 5, 2024 Jan 3, 2024
144 Notice of proposed sale Jan 3, 2024 —
144 Notice of proposed sale Jan 3, 2024 —
144 Notice of proposed sale Jan 3, 2024 —
144 Notice of proposed sale Jan 3, 2024 —
144 Notice of proposed sale Jan 3, 2024 —
4 Insider transaction Nov 9, 2023 Nov 7, 2023
144 Notice of proposed sale Nov 7, 2023 —
SC 13G Ownership over 5% (passive) Sep 1, 2023 —
4 Insider transaction Jul 6, 2023 Jul 3, 2023
4 Insider transaction Jul 6, 2023 Jul 3, 2023
4 Insider transaction Jul 6, 2023 Jul 3, 2023
4 Insider transaction Jul 6, 2023 Jul 3, 2023
4 Insider transaction Jul 6, 2023 Jul 3, 2023
144 Notice of proposed sale Jul 3, 2023 —
144 Notice of proposed sale Jul 3, 2023 —
144 Notice of proposed sale Jul 3, 2023 —
144 Notice of proposed sale Jul 3, 2023 —
144 Notice of proposed sale Jul 3, 2023 —
4 Insider transaction Jun 15, 2023 Jun 13, 2023
4 Insider transaction Jun 15, 2023 Jun 13, 2023
4 Insider transaction Jun 15, 2023 Jun 13, 2023
4 Insider transaction Jun 15, 2023 Jun 13, 2023
4 Insider transaction Jun 15, 2023 Jun 13, 2023
4 Insider transaction Jun 15, 2023 Jun 13, 2023
4 Insider transaction Jun 15, 2023 Jun 13, 2023
144 Notice of proposed sale Jun 13, 2023 —
144 Notice of proposed sale Jun 13, 2023 —
144 Notice of proposed sale Jun 13, 2023 —
144 Notice of proposed sale Jun 13, 2023 —
144 Notice of proposed sale Jun 13, 2023 —
144 Notice of proposed sale Jun 13, 2023 —
4 Insider transaction Jun 6, 2023 Jun 2, 2023
144 Notice of proposed sale Jun 2, 2023 —
4 Insider transaction Feb 14, 2023 Feb 10, 2023
4 Insider transaction Feb 14, 2023 Feb 10, 2023
4 Insider transaction Feb 14, 2023 Feb 10, 2023
4 Insider transaction Feb 14, 2023 Feb 10, 2023
4 Insider transaction Feb 14, 2023 Feb 10, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 7, 2023 —
SC 13G/A Amended ownership over 5% (passive) Jan 19, 2023 —
4 Insider transaction Jan 5, 2023 Jan 3, 2023
4 Insider transaction Jan 5, 2023 Jan 3, 2023
4 Insider transaction Jan 5, 2023 Jan 3, 2023
4 Insider transaction Jan 5, 2023 Jan 3, 2023
4 Insider transaction Jan 5, 2023 Jan 3, 2023
SC 13D/A Amended ownership over 5% (active) Dec 13, 2022 —
4 Insider transaction Dec 12, 2022 Dec 12, 2022
4 Insider transaction Dec 6, 2022 Dec 2, 2022
4 Insider transaction Dec 6, 2022 Dec 2, 2022
4 Insider transaction Dec 6, 2022 Dec 2, 2022
4 Insider transaction Dec 6, 2022 Dec 2, 2022
4 Insider transaction Nov 4, 2022 Nov 2, 2022
4 Insider transaction Nov 4, 2022 Nov 2, 2022
4 Insider transaction Nov 4, 2022 Nov 2, 2022
4 Insider transaction Oct 5, 2022 Oct 3, 2022
4 Insider transaction Oct 5, 2022 Oct 3, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PBYI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Los Angeles, CA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1401667
Former names
INNOVATIVE ACQUISITIONS CORP (until Oct 4, 2011)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.